Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
Eko Health, a leader in AI-powered early detection of heart and lung diseases, has appointed Brent D. Lang to its Board of Directors. Lang, former Chairman and CEO of Vocera Communications, brings over 30 years of healthcare and technology experience. He led Vocera through rapid growth, a successful IPO, and its $3 billion acquisition by Stryker (NYSE: SYK).
This appointment follows Eko's recent achievements, including surpassing 500,000 healthcare providers on its platform, completing a $41 million Series D funding round, and receiving FDA clearance for an AI algorithm aiding heart failure detection during routine exams. Lang's strategic vision is expected to guide Eko's continued innovation and expansion in early disease detection technology.
Eko Health, un leader nella rilevazione precoce delle malattie cardiache e polmonari tramite l'IA, ha nominato Brent D. Lang nel suo Consiglio di Amministrazione. Lang, ex Presidente e CEO di Vocera Communications, porta con sé oltre 30 anni di esperienza nei settori della sanità e della tecnologia. Ha guidato Vocera attraverso una rapida crescita, un'IPO di successo e la d'acquisizione da 3 miliardi di dollari da parte di Stryker (NYSE: SYK).
Questa nomina segue i recenti successi di Eko, tra cui il superamento di 500.000 fornitori di assistenza sanitaria sulla sua piattaforma, il completamento di un round di finanziamento di Serie D da 41 milioni di dollari e l'ottenimento della libera pratica FDA per un algoritmo IA che aiuta nella rilevazione di insufficienza cardiaca durante le visite di routine. La visione strategica di Lang è attesa per guidare l'innovazione e l'espansione continua di Eko nella tecnologia di rilevazione precoce delle malattie.
Eko Health, líder en la detección temprana de enfermedades cardíacas y pulmonares impulsada por IA, ha nombrado a Brent D. Lang en su Junta Directiva. Lang, ex Presidente y CEO de Vocera Communications, aporta más de 30 años de experiencia en el ámbito de la salud y la tecnología. Dirigió a Vocera a través de un rápido crecimiento, una salida a bolsa exitosa y la adquisición de 3 mil millones de dólares por parte de Stryker (NYSE: SYK).
Este nombramiento sigue a los recientes logros de Eko, que incluyen haber superado los 500,000 proveedores de atención médica en su plataforma, haber completado una ronda de financiación Serie D de 41 millones de dólares, y haber recibido la autorización de la FDA para un algoritmo de IA que ayuda en la detección de insuficiencia cardiaca durante exámenes de rutina. Se espera que la visión estratégica de Lang guíe la innovación y expansión continua de Eko en la tecnología de detección temprana de enfermedades.
Eko Health는 AI 기반의 심장 및 폐 질환 감지의 선두주자로서 Brent D. Lang을 이사회에 임명했습니다. Lang은 Vocera Communications의 전 회장 겸 CEO로, 30년 이상의 의료 및 기술 경험을 보유하고 있습니다. 그는 Vocera를 빠른 성장과 성공적인 IPO를 이끌었으며, Stryker(NYSE: SYK)에 의한 30억 달러 인수에도 참여했습니다.
이번 임명은 Eko의 최근 성과에 이은 것으로, 500,000명 이상의 의료 제공자를 플랫폼으로 초과했으며, 4100만 달러 시리즈 D 자금 조달 라운드 완료, 그리고 루틴 검사 중 심부전 감지 지원 AI 알고리즘에 대한 FDA 승인 획득이 포함됩니다. Lang의 전략적 비전은 조기 질병 감지 기술에서 Eko의 지속적인 혁신과 확장을 이끌 것으로 기대됩니다.
Eko Health, un leader dans la détection précoce des maladies cardiaques et pulmonaires grâce à l'IA, a nommé Brent D. Lang à son conseil d'administration. Lang, ancien président et PDG de Vocera Communications, apporte plus de 30 ans d'expérience dans le secteur de la santé et de la technologie. Il a conduit Vocera à travers une croissance rapide, une introduction en bourse réussie et une acquisition de 3 milliards de dollars par Stryker (NYSE : SYK).
Cette nomination fait suite aux récentes réalisations d'Eko, notamment le dépassement de 500 000 prestataires de soins de santé sur sa plateforme, l'achèvement d'une levée de fonds de Série D de 41 millions de dollars et l'obtention dune autorisation de la FDA pour un algorithme d'IA aidant à la détection de l'insuffisance cardiaque lors d'examens de routine. La vision stratégique de Lang devrait guider l'innovation et l'expansion continue d'Eko dans la technologie de détection précoce des maladies.
Eko Health, ein führendes Unternehmen in der KI-gestützten Früherkennung von Herz- und Lungenerkrankungen, hat Brent D. Lang in seinen Vorstand berufen. Lang, ehemaliger Vorsitzender und CEO von Vocera Communications, bringt über 30 Jahre Erfahrung im Gesundheitswesen und in der Technologie mit. Er führte Vocera durch ein schnelles Wachstum, einen erfolgreichen Börsengang und die Übernahme durch Stryker (NYSE: SYK) für 3 Milliarden Dollar.
Diese Ernennung folgt auf die jüngsten Erfolge von Eko, darunter die Überwindung von 500.000 Gesundheitsdienstleistern auf seiner Plattform, den Abschluss einer Serie-D-Finanzierungsrunde über 41 Millionen Dollar und die FDA-Zulassung für einen KI-Algorithmus zur Unterstützung der Erkennung von Herzinsuffizienz bei Routineuntersuchungen. Langs strategische Vision wird erwartet, Eko bei der kontinuierlichen Innovation und Expansion in der Technologie zur Früherkennung von Krankheiten zu leiten.
- Appointment of Brent D. Lang, former CEO of Vocera, to the Board of Directors
- Surpassed 500,000 healthcare providers on the platform
- Completed a $41 million Series D funding round
- Received FDA clearance for AI algorithm to aid heart failure detection
- None.
Lang brings over three decades of healthcare and technology experience, having led Vocera through rapid growth, a successful IPO, and its
"Brent's wealth of experience in healthcare technology and company building, combined with a deep commitment to improving patient outcomes, makes him the perfect partner for Eko as we continue to help clinicians diagnose cardiopulmonary diseases earlier and with greater accuracy," said Connor Landgraf, CEO of Eko Health. "We are thrilled to welcome him to our Board."
Lang's appointment follows significant milestones for Eko, including surpassing 500,000 healthcare providers on the platform, completing a
"It's an honor to join Eko's Board at such a growth inflection point for the company," said Lang. "Eko's technology is revolutionizing the way clinicians detect and manage heart and lung diseases, and I look forward to working with the team to ensure the life-saving platform reaches millions of patients and providers around the world in the coming years."
Beyond his distinguished career in healthcare, Lang is also an Olympic gold medalist, having competed with the 1988 USA Men's Swimming team. He continues to support athletes as an independent director and treasurer for the
About Eko Health
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform, used by over 500,000 healthcare professionals worldwide, allows them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in
Media Contact
Sam
View original content to download multimedia:https://www.prnewswire.com/news-releases/eko-health-announces-appointment-of-brent-lang-former-ceo-of-vocera-to-board-of-directors-302246273.html
SOURCE Eko Health
FAQ
Who is the new Board member appointed by Eko Health?
What experience does Brent Lang bring to Eko Health's Board?
What recent milestones has Eko Health achieved?
How might Brent Lang's appointment impact Eko Health's future?
